Market Place
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations. 
X
Please Wait
Applying Filters...
01 Dr. Reddy's Laboratories Limited (1)
02 Aurobindo Pharma Limited (1)
03 BLUEBAY SHANDONG CO.,LTD (1)
04 DARMERICA, LLC (1)
05 Kyorin Pharmaceutical Group Facility Co., Ltd. (1)
06 MYLAN LABORATORIES LIMITED (1)
01 GATIFLOXACIN (1)
02 GATIFLOXACIN HEMIHYDRATE (1)
03 Gatifloxacin Anhydrous (1)
04 Gatifloxacin Hemihydrate (1)
05 Gatifloxacin Sesquihydrate (2)
01 China (1)
02 India (2)
03 Japan (1)
04 U.S.A (2)
54
PharmaCompass offers a list of Gatifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gatifloxacin manufacturer or Gatifloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gatifloxacin manufacturer or Gatifloxacin supplier.
PharmaCompass also assists you with knowing the Gatifloxacin API Price utilized in the formulation of products. Gatifloxacin API Price is not always fixed or binding as the Gatifloxacin Price is obtained through a variety of data sources. The Gatifloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MolPort-001-738-626 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-001-738-626, including repackagers and relabelers. The FDA regulates MolPort-001-738-626 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-001-738-626 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MolPort-001-738-626 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MolPort-001-738-626 supplier is an individual or a company that provides MolPort-001-738-626 active pharmaceutical ingredient (API) or MolPort-001-738-626 finished formulations upon request. The MolPort-001-738-626 suppliers may include MolPort-001-738-626 API manufacturers, exporters, distributors and traders.
click here to find a list of MolPort-001-738-626 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-001-738-626 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MolPort-001-738-626 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MolPort-001-738-626 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MolPort-001-738-626 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-001-738-626 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MolPort-001-738-626 suppliers with NDC on PharmaCompass.
We have 6 companies offering MolPort-001-738-626
Get in contact with the supplier of your choice:
